6 th Annual Meeting on Pituitary Tumors

6 th Annual Meeting on Pituitary Tumors
» Scarica il Programma

 

ROMA, 28 th – 29 th November 2019
presso Hotel Donna Camilla Savelli

 

DIRETTORE
Prof. Alfredo Pontecorvi

Professor of Endocrinology
Fondazione Policlinico Universitario A. Gemelli
Università Cattolica del Sacro Cuore, Rome

 

RESPONSABILE SCIENTIFICO
Prof.ssa Laura De Marinis
Coordinatore Scientifico del Master Universitario di II Livello in diagnosi e terapia delle patologie
ipotalamo ipofisarie – Policlinico Universitario A. Gemelli, Roma

 

SEGRETERIA SCIENTIFICA
Coordinatori:
Dott. Antonio Bianchi, Dott.ssa Antonella Giampietro

Dr. Massimiliano Andrioli, Sabrina Chiloiro, Dr. Domenico Milardi, Dr.ssa Serena Piacentini, Chiara Bima, Giuseppe Grande, Dr.ssa Marilda Mormando, Linda Tartaglione
UOS di Patologia Ipotalamo-Ipofisaria, Policlinico Universitario A. Gemelli, Roma

 

SEDE DELL’EVENTO
Hotel Donna Camilla Savelli
Via Garibaldi, 27 – Roma – Tel. 06 588861

 

ECM 680 – 275782
Assegnati n. 12 Crediti Formativi ECM

L’evento rientra nel piano formativo ECM 2019 della DOTCOM s.r.l. ed è rivolto alle figure professionali di
Infermiere e di Medico – Chirurgo per le seguenti discipline: Anatomia Patologica, Chirurgia Generale,
Endocrinologia, Gastroenterologia, Genetica Medica, Malattie Metaboliche e Diabetologia, Medicina Interna,
Medicina Nucleare, Neurochirurgia, Neuroradiologia, Oftalmologia, Otorinolaringoiatria, Patologia Clinica
(Laboratorio di Analisi Chimico- Cliniche e Microbiologia), Radiodiagnostica, Radioterapia.

 

PRE-ISCRIZIONE
L’iscrizione è gratuita e potrà essere effettuata inviando un email al seguente indirizzo: info@dotcomeventi.com
L’accesso in aula è riservato ai primi 100 partecipanti. Si ricorda che l’attestazione dei crediti ottenuti è subordinata
alla partecipazione del 90% della durata dei lavori, alla compilazione della scheda di valutazione
dell’evento e al superamento della prova di apprendimento (questionario, almeno 75% risposte esatte).

 

OBIETTIVO FORMATIVO
Documentazione Clinica. Percorsi Clinico-Assistenziali Diagnostici e Riabilitativi, Profili di Assistenza –
Profili di Cura.

 

RAZIONALE
Pituitary neuroendocrine tumour (Pit-NET) represents a complex disease. The clinical manifestations
of Pit-NETs are multiple and heterogeneous, according to the ability of secreting
different hormones or pro-hormones and of invading the neighbouring anatomical structures,
such as the same pituitary gland, the optical chiasm, the cavernous sinus, the bone, the
third ventricle and the ventricular system.
In the most recent years, a better definition of these neoplasia was researched in order to
identify biomarkers able to predict the natural history of Pit-NET and their responsiveness to
the different treatments.
Until now, the classifications of the neoplasms arising from adeno-hypophysial cells have
been misleading because of their poor reproducibility and their weak ability in predicting the
aggressiveness, the prognosis, and the outcome of these neoplasia. The 2004 WHO classification
distinguished pituitary adenoma in typical and atypical ones according to the detection
of mitoses and according to the expression of Ki-67 or p53. The 2004 WHO classification
however failed in identifying pituitary tumours refractory to medical, surgical or radiation
therapies or able to regrowth or to metastasize. Similarly, the new 2017 WHO classification
lacks in defining the prognosis of pituitary neoplasia. Invasive, recurrent and proliferative
pituitary neoplasia cause significant morbidity, in particular in cases of persistence hormonal
hyper-secretion. Both long term hormonal hyper-secretion and hypopituitarism, in absence
of an adequate hormonal replacement therapy, are associated to increased morbidity and
mortality for their systemic complications.
Therefore, recently, pituitary adenomas were recognised as neuroendocrine tumors (NETs).
This new terminology of pituitary neuroendocrine tumor (PitNET) reflects better the potential
for aggressiveness and malignant behaviour and of these neoplasia.
On this basis, in the recent years, a wide number of research investigated the genetic, molecular
and biological features of PitNET, in order to predict the clinical behaviour of these
neoplasia. The current event, has the aim of updating participants on the latest biological,
genetic and clinical acquisitions on PitNET and on their impact in the management of PitNet
affected patients.
The meeting is part of the teaching activities of the Master Degree in Diagnosis and Treatment
of pituitary disease (2019) – Faculty of Medicine, Universita’ Cattolica del Sacro Cuore, Rome.

 

LINGUE UFFICIALI
Italiano/Inglese

 

PROVIDER E SEGRETERIA ORGANIZZATIVA
logo-Dotcom-per-eventi
DOTCOM SRL
Via Flaminia, 54 | 00196 Roma
Tel. 06 4061370 | Fax 06 3242600
E-Mail: info@dotcomeventi.com
Sito web: www.dotcomeventi.com

 

 

 

Con la sponsorizzazione non condizionante di



 

 

Medici - U.O.S. Ipofisi

View more posts from this author